Evidence map›Paper›PMID 37747931›Full record

ArticlePLoS pathogens2023

Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection.

Patricia Aguilar-Calvo, Adela Malik, Daniel R Sandoval, Christopher Barback, Christina D Orrù, Heidi G Standke, Olivia R Thomas, Chrissa A Dwyer, Donald P Pizzo, Jaidev Bapat and 10 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Tracking Prions by RT-QuIC: An Update.Sub-cellular biochemistry · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Patricia Aguilar-CalvoDepartment of Pathology, UC San Diego, La Jolla, California, United States of America.
Adela MalikDepartment of Pathology, UC San Diego, La Jolla, California, United States of America.
Daniel R SandovalDepartment of Cellular and Molecular Medicine, UC San Diego, La Jolla, California, United States of America.
Christopher BarbackDepartment of Radiology, UC San Diego, La Jolla, California, United States of America.
Christina D OrrùLaboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America.
Heidi G StandkeDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Olivia R ThomasDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Chrissa A DwyerDepartment of Cellular and Molecular Medicine, UC San Diego, La Jolla, California, United States of America.
Donald P PizzoDepartment of Pathology, UC San Diego, La Jolla, California, United States of America.
Jaidev BapatDepartment of Pathology, UC San Diego, La Jolla, California, United States of America.
Katrin SoldauDepartment of Pathology, UC San Diego, La Jolla, California, United States of America.
Ryotaro OgawaDepartment of Radiology, UC San Diego, La Jolla, California, United States of America.
Mckenzie B RileyDepartment of Neurology, University of Alabama, Birmingham, Alabama, United States of America.
K Peter R NilssonDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Allison KrausDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Byron CaugheyLaboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America.
Jeffrey J IliffVISN 20 NW Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, United States of America.
David R VeraDepartment of Radiology, UC San Diego, La Jolla, California, United States of America.
Jeffrey D EskoDepartment of Cellular and Molecular Medicine, UC San Diego, La Jolla, California, United States of America.
Christina J SigurdsonDepartment of Pathology, UC San Diego, La Jolla, California, United States of America.ORCID 0000-0002-1770-0965
University of California San Diego · USCase Western Reserve University · USLinköping University · SEUniversity of Alabama at Birmingham · USUniversity of Washington · US

Funding

Protein Glycosylation in the Coagulopathy and Inflammation of SepsisP01HL131474 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARTH, JAMEY · 2016 to 2025
$26.2M
Mechanisms of Prion Aggregation and Species BarriersR01NS069566 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D, RAVITS, JOHN · 2011 to 2025
$5.7M
Mechanisms of Prion SpreadR01NS076896 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2012 to 2021
$3.4M
Mechanisms of Prion Spread and Neuronal ToxicityR37NS076896 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christina Sigurdson · 2023 to 2026
$2.6M
Molecular basis of prion protein-induced neurodegenerationRF1NS121992 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2021 to 2023
$1.7M
Molecular basis of prion protein-induced neurodegenerationR01NS121992 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2024 to 2025
$963k
Role of heparan sulfate in neural cell vulnerability to prionsR00AG061251 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGUILAR CALVO, PATRICIA · 2022 to 2024
$747k
Determining pathogenic PrPC-induced signaling pathways in human iPSC-induced neuronsR21NS135426 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2023 to 2023
$435k
Role of heparan sulfate in neural cell vulnerability to prionsK99AG061251 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AGUILAR CALVO, PATRICIA · 2019 to 2021
$375k
NHLBI NIH HHS P01 HL131474NIA NIH HHS K99 AG061251NIA NIH HHS R00 AG061251NINDS NIH HHS R01 NS069566NINDS NIH HHS R01 NS076896NINDS NIH HHS R01 NS121992NINDS NIH HHS R21 NS135426NINDS NIH HHS R37 NS076896NINDS NIH HHS RF1 NS121992
6 · The paper itself

Abstract

Select prion diseases are characterized by widespread cerebral plaque-like deposits of amyloid fibrils enriched in heparan sulfate (HS), a abundant extracellular matrix component. HS facilitates fibril formation in vitro, yet how HS impacts fibrillar plaque growth within the brain is unclear. Here we found that prion-bound HS chains are highly sulfated, and that the sulfation is essential for accelerating prion conversion in vitro. Using conditional knockout mice to deplete the HS sulfation enzyme, Ndst1 (N-deacetylase / N-sulfotransferase) from neurons or astrocytes, we investigated how reducing HS sulfation impacts survival and prion aggregate distribution during a prion infection. Neuronal Ndst1-depleted mice survived longer and showed fewer and smaller parenchymal plaques, shorter fibrils, and increased vascular amyloid, consistent with enhanced aggregate transit toward perivascular drainage channels. The prolonged survival was strain-dependent, affecting mice infected with extracellular, plaque-forming, but not membrane bound, prions. Live PET imaging revealed rapid clearance of recombinant prion protein monomers into the CSF of neuronal Ndst1- deficient mice, neuronal, further suggesting that HS sulfate groups hinder transit of extracellular prion protein monomers. Our results directly show how a host cofactor slows the spread of prion protein through the extracellular space and identify an enzyme to target to facilitate aggregate clearance.

Indexed as

NeuronsPrion DiseasesPrionsSulfotransferasesAnimalsHeparan SulfateMiceMice, KnockoutPrion ProteinsHeparan Sulfateheparitin sulfotransferasePrion ProteinsPrionsSulfotransferases

Identifiers

PMID37747931
PMCPMC10586673
OpenAlexW4387011792

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.